ala pharma ltd Company Information
Company Number
08364504
Website
www.ala-care.comRegistered Address
beda house clough dene, tantobie, stanley, DH9 9PN
Industry
Other human health activities
Telephone
01914885615
Next Accounts Due
April 2025
Group Structure
View All
Directors
Monju Miah6 Years
Shareholders
monju miah 100%
ala pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of ALA PHARMA LTD at £51.2k based on a Turnover of £93.2k and 0.55x industry multiple (adjusted for size and gross margin).
ala pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of ALA PHARMA LTD at £0 based on an EBITDA of £-3.3k and a 4.82x industry multiple (adjusted for size and gross margin).
ala pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of ALA PHARMA LTD at £378.5k based on Net Assets of £159.3k and 2.38x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Ala Pharma Ltd Overview
Ala Pharma Ltd is a live company located in stanley, DH9 9PN with a Companies House number of 08364504. It operates in the other human health activities sector, SIC Code 86900. Founded in January 2013, it's largest shareholder is monju miah with a 100% stake. Ala Pharma Ltd is a established, micro sized company, Pomanda has estimated its turnover at £93.2k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Ala Pharma Ltd Health Check
Pomanda's financial health check has awarded Ala Pharma Ltd a 1 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 4 areas for improvement. Company Health Check FAQs
0 Strong
3 Regular
4 Weak
Size
annual sales of £93.2k, make it smaller than the average company (£667.7k)
- Ala Pharma Ltd
£667.7k - Industry AVG
Growth
3 year (CAGR) sales growth of -52%, show it is growing at a slower rate (5.6%)
- Ala Pharma Ltd
5.6% - Industry AVG
Production
with a gross margin of 37.4%, this company has a comparable cost of product (37.4%)
- Ala Pharma Ltd
37.4% - Industry AVG
Profitability
an operating margin of -3.5% make it less profitable than the average company (5.7%)
- Ala Pharma Ltd
5.7% - Industry AVG
Employees
with 2 employees, this is below the industry average (17)
2 - Ala Pharma Ltd
17 - Industry AVG
Pay Structure
on an average salary of £25.2k, the company has an equivalent pay structure (£25.2k)
- Ala Pharma Ltd
£25.2k - Industry AVG
Efficiency
resulting in sales per employee of £46.6k, this is equally as efficient (£46.6k)
- Ala Pharma Ltd
£46.6k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Ala Pharma Ltd
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Ala Pharma Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Ala Pharma Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Ala Pharma Ltd
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Ala Pharma Ltd
- - Industry AVG
ALA PHARMA LTD financials
Ala Pharma Ltd's latest turnover from July 2023 is estimated at £93.2 thousand and the company has net assets of £159.3 thousand. According to their latest financial statements, Ala Pharma Ltd has 2 employees and maintains cash reserves of £14.3 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Jul 2019 | Jul 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Jul 2014 | Jul 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||
Other Income Or Grants | |||||||||||
Cost Of Sales | |||||||||||
Gross Profit | |||||||||||
Admin Expenses | |||||||||||
Operating Profit | |||||||||||
Interest Payable | |||||||||||
Interest Receivable | |||||||||||
Pre-Tax Profit | |||||||||||
Tax | |||||||||||
Profit After Tax | |||||||||||
Dividends Paid | |||||||||||
Retained Profit | |||||||||||
Employee Costs | |||||||||||
Number Of Employees | 2 | 2 | 2 | 4 | 4 | ||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Jul 2019 | Jul 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Jul 2014 | Jul 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 145,000 | 145,000 | 145,000 | 145,000 | 269,410 | 278,637 | 287,984 | 297,480 | 305,970 | 168,671 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 145,000 | 145,000 | 145,000 | 145,000 | 269,410 | 278,637 | 287,984 | 297,480 | 305,970 | 168,671 | 0 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 0 | 0 | 0 | 137,900 | 143,497 | 127,257 | 139,953 | 151,628 | 126,876 | 90,138 | 0 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 14,318 | 16,839 | 59,232 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 14,318 | 16,839 | 59,232 | 137,900 | 143,497 | 127,257 | 139,953 | 151,628 | 126,876 | 90,138 | 0 |
total assets | 159,318 | 161,839 | 204,232 | 282,900 | 412,907 | 405,894 | 427,937 | 449,108 | 432,846 | 258,809 | 0 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 0 | 0 | 0 | 24,826 | 69,893 | 59,301 | 53,210 | 81,328 | 66,896 | 64,944 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 0 | 0 | 0 | 24,826 | 69,893 | 59,301 | 53,210 | 81,328 | 66,896 | 64,944 | 0 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 42,240 | 94,574 | 301,952 | 288,451 | 319,454 | 323,909 | 341,534 | 184,655 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 42,240 | 94,574 | 301,952 | 288,451 | 319,454 | 323,909 | 341,534 | 184,655 | 0 |
total liabilities | 0 | 0 | 42,240 | 119,400 | 371,845 | 347,752 | 372,664 | 405,237 | 408,430 | 249,599 | 0 |
net assets | 159,318 | 161,839 | 161,992 | 163,500 | 41,062 | 58,142 | 55,273 | 43,871 | 24,416 | 9,210 | 0 |
total shareholders funds | 159,318 | 161,839 | 161,992 | 163,500 | 41,062 | 58,142 | 55,273 | 43,871 | 24,416 | 9,210 | 0 |
Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Jul 2019 | Jul 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Jul 2014 | Jul 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||
Operating Profit | |||||||||||
Depreciation | 0 | 0 | 0 | 0 | |||||||
Amortisation | 0 | 0 | 0 | 0 | |||||||
Tax | |||||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 0 | 0 | -137,900 | -5,597 | 16,240 | -12,696 | -11,675 | 24,752 | 36,738 | 90,138 | 0 |
Creditors | 0 | 0 | -24,826 | -45,067 | 10,592 | 6,091 | -28,118 | 14,432 | 1,952 | 64,944 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | |||||||||||
Investing Activities | |||||||||||
capital expenditure | |||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||
Financing Activities | |||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | -42,240 | -52,334 | -207,378 | 13,501 | -31,003 | -4,455 | -17,625 | 156,879 | 184,655 | 0 |
share issue | |||||||||||
interest | |||||||||||
cash flow from financing | |||||||||||
cash and cash equivalents | |||||||||||
cash | -2,521 | -42,393 | 59,232 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -2,521 | -42,393 | 59,232 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ala pharma ltd Credit Report and Business Information
Ala Pharma Ltd Competitor Analysis
Perform a competitor analysis for ala pharma ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in DH9 area or any other competitors across 12 key performance metrics.
ala pharma ltd Ownership
ALA PHARMA LTD group structure
Ala Pharma Ltd has no subsidiary companies.
Ultimate parent company
ALA PHARMA LTD
08364504
ala pharma ltd directors
Ala Pharma Ltd currently has 1 director, Mr Monju Miah serving since Jun 2018.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Monju Miah | United Kingdom | 39 years | Jun 2018 | - | Director |
P&L
July 2023turnover
93.2k
+5%
operating profit
-3.3k
0%
gross margin
37.5%
+1.65%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
July 2023net assets
159.3k
-0.02%
total assets
159.3k
-0.02%
cash
14.3k
-0.15%
net assets
Total assets minus all liabilities
ala pharma ltd company details
company number
08364504
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
January 2013
age
11
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
July 2023
previous names
N/A
accountant
-
auditor
-
address
beda house clough dene, tantobie, stanley, DH9 9PN
Bank
-
Legal Advisor
-
ala pharma ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to ala pharma ltd. Currently there are 2 open charges and 2 have been satisfied in the past.
ala pharma ltd Companies House Filings - See Documents
date | description | view/download |
---|